XTX Topco Ltd Invests $78,000 in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)

XTX Topco Ltd bought a new stake in shares of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) in the third quarter, Holdings Channel reports. The fund bought 62,785 shares of the company’s stock, valued at approximately $78,000.

Separately, Renaissance Technologies LLC purchased a new stake in SELLAS Life Sciences Group in the 2nd quarter worth approximately $39,000. Institutional investors and hedge funds own 17.38% of the company’s stock.

SELLAS Life Sciences Group Price Performance

NASDAQ:SLS opened at $0.89 on Friday. The company has a 50 day moving average price of $1.15 and a 200-day moving average price of $1.21. SELLAS Life Sciences Group, Inc. has a 1-year low of $0.50 and a 1-year high of $1.72. The firm has a market cap of $62.50 million, a price-to-earnings ratio of -1.29 and a beta of 2.39.

SELLAS Life Sciences Group Company Profile

SELLAS Life Sciences Group, Inc, a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company’s lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.